Amphastar Pharmaceuticals, Inc. · Brief

Next report

5 days

Nov 5 · after closeconfirmedQ3 FY26

Expected move

No implied move.

8 reportsHistory

3 of 8≥ implied

Nov 6 '24±8.9%▼−13.69%×1.54

Feb 27 '25±11.0%▼−9.72%×0.88

May 7 '25±19.5%▲+0.90%×0.05

Aug 7 '25±11.3%▲+10.13%×0.89

Q3 FY25±14.4%▼−0.83%×0.06

Q1 FY26±15.6%▼−23.63%×1.51

May 7 '26±13.2%▼−20.93%×1.58

Q2 FY26±22.3%▲+4.90%×0.22

quarterimplied−25%0+25%realized×

Q2 FY26±22.3%▲+4.90%×0.22

May '26±13.2%▼−20.93%×1.58

Q1 FY26±15.6%▼−23.63%×1.51

Q3 FY25±14.4%▼−0.83%×0.06

Aug '25±11.3%▲+10.13%×0.89

May '25±19.5%▲+0.90%×0.05

2 older reports

Feb '25±11.0%▼−9.72%×0.88

Nov '24±8.9%▼−13.69%×1.54

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 5 report · confirmed

Bull2

209managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+0.27%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2

12 of 25of the largest reporting managers cut their stake in the latest quarter13F · Jun 30 '26

0.02%of iShares Russell 2000 ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

AMPH report session

No linked exposure.

Oct 29report dateEarnings date confirmed: Nov 5, after close.Source

Oct 22impliedImplied move: ±15.5% into Nov 5 earnings (Oct 22 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.